| dbo:abstract
|
- The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021. This is the country's largest-ever immunization campaign, aiming to administer over 150 million doses. As of 6 April 2022, Vietnam has administered 207,235,119 vaccine doses across the country. (en)
- Vaksinasi COVID-19 di Vietnam adalah sebuah kampanye imunisasi terkini melawan (SARS-CoV-2), virus yang menyebabkan penyakit koronavirus 2019 (COVID-19), dalam menanggapi pandemi terkini di negara tersebut. Usai penyepakatan vaksin COVID-19 Oxford–AstraZeneca pada 30 Januari 2021, vaksinasi dimulai pada 8 Maret 2021. kemudian sepakat untuk dipakai pada 23 Maret 2021. Ini adalah kampanye imunisasi terbesar negara tersebut dengan lebih dari 150 juta dosis. Negara tersebut direncanakan mencapai target vaksinasi 80% pada Juni 2022. Meskipun Vietnam memiliki cerita sukses dalam pencegahan penyakit dan menjaga wabah berada di bawah kendali, program vaksinasi COVID-19 di negara tersebut dianggap lebih lambat ketimbang negara-negara lain di wilayah Asia-Pasifik. Vietnam menyetujui penggunaan Abdala dari pada 18 September 2021, dan dari Bharat Biotech pada 10 November 2021. (in)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 111065 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:budget
|
- 25200000000000 (xsd:decimal)
|
| dbp:caption
|
- 0001-03-13 (xsd:gMonthDay)
- Number of administered second doses : (en)
- Daily COVID-19 vaccine doses administered in Vietnam (en)
- Number of people who received at least one dose of COVID-19 vaccine in Vietnam (en)
|
| dbp:cause
| |
| dbp:color
|
- #FF6600 (en)
- #e3ffff (en)
- #edb7e9 (en)
- #ffdab0 (en)
- #fffa75 (en)
|
| dbp:date
| |
| dbp:description
|
- Phase I : Open label, dose escalation. (en)
- Phase II : Randomized, observer-blind. (en)
- Phase I/II/III : Randomized, double-blinded, placebo controlled. (en)
- Phase II : Randomization, double-blind, multicenter, placebo-controlled. (en)
|
| dbp:endphase
| |
| dbp:image
|
- Daily COVID-19 vaccine doses administered in Vietnam.svg (en)
- CoronavirusdataexplorerVietnam.svg (en)
|
| dbp:label
|
- AstraZeneca (en)
- Government procurement (en)
- Abdala (en)
- COVAX (en)
- Foreign government aid (en)
- Pfizer and Moderna (en)
- Private enterprise (en)
- Sinopharm (en)
- Sputnik V and Sputnik Light (en)
|
| dbp:organisers
| |
| dbp:outcome
|
- percent of the Vietnamese population is fully vaccinated. (en)
- percent of the Vietnamese population has received at least one dose. (en)
|
| dbp:participants
|
- 495 (xsd:integer)
- 620 (xsd:integer)
- 13000 (xsd:integer)
- 21000 (xsd:integer)
- people with at least one dose administered of COVID-19 vaccine. (en)
- people have been fully vaccinated. (en)
|
| dbp:phase
|
- 1 (xsd:integer)
- 3 (xsd:integer)
- pre (en)
|
| dbp:status
|
- Awaited for the conduct on Phase I trial (en)
|
| dbp:style
| |
| dbp:target
|
- Immunization against COVID-19 (en)
|
| dbp:title
|
- COVID-19 vaccination in Vietnam (en)
|
| dbp:value
|
- 5150000 (xsd:integer)
- 26863398 (xsd:integer)
- 31786300 (xsd:integer)
- 52261200 (xsd:integer)
- 56831620 (xsd:integer)
- 63957876 (xsd:integer)
- 106326166 (xsd:integer)
- (1508998+100000)/221807484*100round2 (en)
- (84752250+14077160)/221807484*100round2 (en)
|
| dbp:whenwhere
|
- Aug–Dec 2021, Vietnam (en)
- Dec 2020Jun 2021, Vietnam (en)
- Jun–Sep 2021, Vietnam (en)
- Mar 2021Dec 2021, Vietnam (en)
|
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and B (en)
- Vaksinasi COVID-19 di Vietnam adalah sebuah kampanye imunisasi terkini melawan (SARS-CoV-2), virus yang menyebabkan penyakit koronavirus 2019 (COVID-19), dalam menanggapi pandemi terkini di negara tersebut. Usai penyepakatan vaksin COVID-19 Oxford–AstraZeneca pada 30 Januari 2021, vaksinasi dimulai pada 8 Maret 2021. kemudian sepakat untuk dipakai pada 23 Maret 2021. Ini adalah kampanye imunisasi terbesar negara tersebut dengan lebih dari 150 juta dosis. Negara tersebut direncanakan mencapai target vaksinasi 80% pada Juni 2022. (in)
|
| rdfs:label
|
- COVID-19 vaccination in Vietnam (en)
- Vaksinasi Covid-19 di Vietnam (in)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
.jpg){kind=link}
.jpg){kind=link}
